Annovis Bio Inc. (ANVS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Annovis Bio Inc.

    NYSE: ANVS · Real-Time Price · USD
    2.21
    -0.02 (-0.90%)
    At close: Oct 03, 2025, 3:59 PM
    2.22
    0.41%
    After-hours: Oct 03, 2025, 06:50 PM EDT

    Annovis Bio Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 10.55M 5.75M 28.38M 45.69M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a 20.8K 11.24K 9.87K
    Total Current Assets
    		 13.93M 10.21M 36.02M 46M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a n/a
    Total Assets
    		 13.93M 10.21M 36.02M 46M
    Account Payables
    		 2.31M 1.29M 3.96M 688.07K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 1.21M 273.00 285.00 n/a
    Total Current Liabilities
    		 3.88M 4.28M 7.7M 1.51M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 737K 13.68M n/a n/a
    Total Long-Term Liabilities
    		 737K 13.68M 3.96M n/a
    Total Liabilities
    		 4.62M 17.96M 7.7M 1.51M
    Total Debt
    		 n/a n/a n/a n/a
    Book Value
    		 9.31M -7.75M 28.32M 44.49M
    Book Value Per Share
    		 0.76 -0.86 3.47 5.83
    Common Stock
    		 1.41K 1.05K 816.00 810.00
    Retained Earnings
    		 -134.85M -110.26M -54.05M -28.73M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 9.31M -7.75M 28.32M 44.49M
    Total Investments
    		 10.54B n/a n/a n/a

    Add to Watchlist